These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 17051424)

  • 1. In vivo proton magnetic resonance spectroscopy of breast lesions: an update.
    Tse GM; Yeung DK; King AD; Cheung HS; Yang WT
    Breast Cancer Res Treat; 2007 Sep; 104(3):249-55. PubMed ID: 17051424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preliminary study of 3T 1H MR spectroscopy in bone and soft tissue tumors.
    Qi ZH; Li CF; Li ZF; Zhang K; Wang Q; Yu DX
    Chin Med J (Engl); 2009 Jan; 122(1):39-43. PubMed ID: 19187615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of total choline from in-vivo volume localized proton MR spectroscopy and its response to neoadjuvant chemotherapy in locally advanced breast cancer.
    Jagannathan NR; Kumar M; Seenu V; Coshic O; Dwivedi SN; Julka PK; Srivastava A; Rath GK
    Br J Cancer; 2001 Apr; 84(8):1016-22. PubMed ID: 11308247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved diagnostic accuracy in differentiating malignant and benign lesions using single-voxel proton MRS of the breast at 3 T MRI.
    Suppiah S; Rahmat K; Mohd-Shah MN; Azlan CA; Tan LK; Aziz YF; Vijayananthan A; Wui AL; Yip CH
    Clin Radiol; 2013 Sep; 68(9):e502-10. PubMed ID: 23706826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring the therapeutic response of locally advanced breast cancer patients: sequential in vivo proton MR spectroscopy study.
    Kumar M; Jagannathan NR; Seenu V; Dwivedi SN; Julka PK; Rath GK
    J Magn Reson Imaging; 2006 Aug; 24(2):325-32. PubMed ID: 16786567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton magnetic resonance spectroscopy and diffusion-weighted imaging in intracranial cystic mass lesions.
    Lai PH; Hsu SS; Ding SW; Ko CW; Fu JH; Weng MJ; Yeh LR; Wu MT; Liang HL; Chen CK; Pan HB
    Surg Neurol; 2007; 68 Suppl 1():S25-36. PubMed ID: 17963918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinally monitoring chemotherapy effect of malignant musculoskeletal tumors with in vivo proton magnetic resonance spectroscopy: an initial experience.
    Hsieh TJ; Li CW; Chuang HY; Liu GC; Wang CK
    J Comput Assist Tomogr; 2008; 32(6):987-94. PubMed ID: 19204465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined DCE-MRI and single-voxel 2D MRS for differentiation between benign and malignant breast lesions.
    Lipnick S; Liu X; Sayre J; Bassett LW; Debruhl N; Thomas MA
    NMR Biomed; 2010 Oct; 23(8):922-30. PubMed ID: 20878970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of contrast agent on the results of in vivo ¹H MRS of breast tumors - is it clinically significant?
    Baltzer PA; Gussew A; Dietzel M; Rzanny R; Gajda M; Camara O; Reichenbach JR; Kaiser WA
    NMR Biomed; 2012 Jan; 25(1):67-74. PubMed ID: 21557368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of breast cancer using two-dimensional MRS.
    Thomas MA; Lipnick S; Velan SS; Liu X; Banakar S; Binesh N; Ramadan S; Ambrosio A; Raylman RR; Sayre J; DeBruhl N; Bassett L
    NMR Biomed; 2009 Jan; 22(1):77-91. PubMed ID: 19086016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of lesions of the breast with proton MR spectroscopy: comparison of carcinomas, benign lesions, and phyllodes tumors.
    Tse GM; Cheung HS; Pang LM; Chu WC; Law BK; Kung FY; Yeung DK
    AJR Am J Roentgenol; 2003 Nov; 181(5):1267-72. PubMed ID: 14573418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ex vivo proton MR spectroscopy (1H-MRS) for evaluation of human gastric carcinoma.
    Mun CW; Cho JY; Shin WJ; Choi KS; Eun CK; Cha SS; Lee J; Yang YI; Nam SH; Kim J; Lee SY
    Magn Reson Imaging; 2004 Jul; 22(6):861-70. PubMed ID: 15234456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proton MR spectroscopy of the breast.
    Tozaki M
    Breast Cancer; 2008; 15(3):218-23. PubMed ID: 18443899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton magnetic resonance spectroscopy of tubercular breast abscess: report of a case.
    Das CJ; Medhi K
    J Comput Assist Tomogr; 2008; 32(4):599-601. PubMed ID: 18664848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo magnetic resonance spectroscopy of gynaecological tumours at 3.0 Tesla.
    Booth SJ; Pickles MD; Turnbull LW
    BJOG; 2009 Jan; 116(2):300-3. PubMed ID: 19076962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application value of 3T ¹H-magnetic resonance spectroscopy in diagnosing breast tumors.
    Vassiou K; Tsougos I; Kousi E; Vlychou M; Athanasiou E; Theodorou K; Arvanitis DL; Fezoulidis IV
    Acta Radiol; 2013 May; 54(4):380-8. PubMed ID: 23436823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proton magnetic resonance spectroscopy of musculoskeletal lesions at 3 T with metabolite quantification.
    Lee CW; Lee JH; Kim DH; Min HS; Park BK; Cho HS; Kang HG; Suh JS; Ehara S
    Clin Imaging; 2010; 34(1):47-52. PubMed ID: 20122519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fine-needle biopsy specimens of benign breast lesions distinguished from invasive cancer ex vivo with proton MR spectroscopy.
    Mackinnon WB; Barry PA; Malycha PL; Gillett DJ; Russell P; Lean CL; Doran ST; Barraclough BH; Bilous M; Mountford CE
    Radiology; 1997 Sep; 204(3):661-6. PubMed ID: 9280241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proton MRS of the breast in the clinical setting.
    Mountford C; Ramadan S; Stanwell P; Malycha P
    NMR Biomed; 2009 Jan; 22(1):54-64. PubMed ID: 19086012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative multivoxel proton chemical shift imaging of the breast.
    Sijens PE; Dorrius MD; Kappert P; Baron P; Pijnappel RM; Oudkerk M
    Magn Reson Imaging; 2010 Apr; 28(3):314-9. PubMed ID: 20071119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.